467 related articles for article (PubMed ID: 27044796)
41. Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.
Ferreira AC; Fernandes V; Rodrigues A; Abreu CP; Pereira M; Guedes AM; Gomes AM; Cabrita A; Soares C; Pego C; Ferrer F; Bernardo I; Fernandes JC; Assunção J; Oliveira L; Amoedo M; Carvalho MJ; Branco P; Maia P; Chorão R; Castro R; Silva R; Sousa T; Mendes T;
Blood Purif; 2023; 52(4):366-372. PubMed ID: 36702111
[TBL] [Abstract][Full Text] [Related]
42. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
Lim CT; Wong KS; Foo MW
Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
[TBL] [Abstract][Full Text] [Related]
43. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
Cho KH; DO JY; Park JW; Yoon KW
Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
[TBL] [Abstract][Full Text] [Related]
44. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
Sethna CB; Bryant K; Munshi R; Warady BA; Richardson T; Lawlor J; Newland JG; Neu A;
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1590-1596. PubMed ID: 27340282
[TBL] [Abstract][Full Text] [Related]
45. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.
Johnson DW; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM;
Lancet Infect Dis; 2014 Jan; 14(1):23-30. PubMed ID: 24119840
[TBL] [Abstract][Full Text] [Related]
46. Pseudomonas exit-site infection: treatment outcomes with topical gentamicin in addition to systemic antibiotics.
Burkhalter F; Clemenger M; Haddoub SS; McGrory J; Hisole N; Brown E
Clin Kidney J; 2015 Dec; 8(6):781-4. PubMed ID: 26613039
[TBL] [Abstract][Full Text] [Related]
47. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
Araki Y; Hataya H; Ikeda M; Ishikura K; Honda M
Perit Dial Int; 2003; 23(3):267-9. PubMed ID: 12938828
[TBL] [Abstract][Full Text] [Related]
48. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
49. Peritoneal Dialysis-Associated Peritonitis.
Szeto CC; Li PK
Clin J Am Soc Nephrol; 2019 Jul; 14(7):1100-1105. PubMed ID: 31068338
[TBL] [Abstract][Full Text] [Related]
50. A Retrospective Sequential Comparison of Topical Application of Medicated Honey and Povidone Iodine for Preventing Peritoneal Dialysis Catheter-Related Infections.
Wishart TFL; Aw L; Byth K; Rangan G; Sud K
Perit Dial Int; 2018; 38(4):302-305. PubMed ID: 29987066
[TBL] [Abstract][Full Text] [Related]
51. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.
Johnson DW; MacGinley R; Kay TD; Hawley CM; Campbell SB; Isbel NM; Hollett P
Nephrol Dial Transplant; 2002 Oct; 17(10):1802-7. PubMed ID: 12270988
[TBL] [Abstract][Full Text] [Related]
52. Chlorhexidine for routine PD catheter exit-site care.
Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
[TBL] [Abstract][Full Text] [Related]
53. Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: a cost-effectiveness analysis.
Wong C; Luk IW; Ip M; You JH
Am J Infect Control; 2014 Apr; 42(4):412-6. PubMed ID: 24679568
[TBL] [Abstract][Full Text] [Related]
54. Clinical Value of Screening Peritoneal Dialysis Patients for Bacterial Colonization or Contamination.
Parthasarathy R; Kashem T; NicFhogartaigh C; Melzer M; Fan SL
Perit Dial Int; 2019; 39(2):126-133. PubMed ID: 30739095
[TBL] [Abstract][Full Text] [Related]
55. Shewanella algae Peritonitis in Patients on Peritoneal Dialysis.
Shanmuganathan M; Goh BL; Lim C; NorFadhlina Z; Fairol I
Perit Dial Int; 2016 9-10; 36(5):574-5. PubMed ID: 27659933
[TBL] [Abstract][Full Text] [Related]
56. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
[No Abstract] [Full Text] [Related]
57. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
Szeto CC; Chow KM; Leung CB; Wong TY; Wu AK; Wang AY; Lui SF; Li PK
Kidney Int; 2001 Jun; 59(6):2309-15. PubMed ID: 11380835
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
Cochrane Database Syst Rev; 2004 Oct; (4):CD004679. PubMed ID: 15495124
[TBL] [Abstract][Full Text] [Related]
59. Repeat Peritoneal Dialysis Exit-Site Infection: Definition and Outcomes.
Beckwith H; Clemenger M; McGrory J; Hisole N; Chelapurath T; Newbury S; Corbett RW; Brown EA
Perit Dial Int; 2019; 39(4):344-349. PubMed ID: 31123072
[No Abstract] [Full Text] [Related]
60. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
